Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;85(4):465-476.e1.
doi: 10.1053/j.ajkd.2024.10.009. Epub 2024 Dec 26.

Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140

Collaborators, Affiliations
Free article

Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140

Nikola Zagorec et al. Am J Kidney Dis. 2025 Apr.
Free article

Abstract

Rationale & objective: Monoallelic predicted loss-of-function (pLoF) variants in IFT140 have recently been associated with an autosomal dominant polycystic kidney disease (ADPKD)-like phenotype. This study enhanced the characterization of this phenotype.

Study design: Case series.

Setting & participants: Seventy-five among 2,797 European individuals with ADPKD-like phenotypes who underwent genetic testing that revealed pLoF IFT140-variants.

Findings: The 75 individuals (median age 56 years, 53.3% females) were from 61 families and were found to have 41 different monoallelic pLoF IFT140-variants. The majority of individuals presented with large, exophytic kidney cysts (median total kidney volume, 688mL [IQR, 201-4,139]), and 90.2% were classified using the Mayo Imaging Classification as Mayo Class 2A. Arterial hypertension was present in 50.7% of the individuals (median age at diagnosis, 59 years [IQR, 29-73]). Only 1 patient developed kidney failure (at age 69 years). A significant difference was observed in the age-adjusted estimated glomerular filtration rate (eGFR) between the male and female patients (P<0.001), and 56.3% of the individuals over the age of 60 years had an eGFR of<60mL/min/1.73m2. The estimated genetic prevalence of monoallelic pLoF IFT140 variants was 19.76 (95% CI, 18.8-20.7) and 27.89 (95% CI, 23.8-31.9) per 10,000 in the Genome Aggregation Database and the 100,000 Genomes Project (100kG), respectively. Only cystic kidney disease (ICD-10 Q61) was associated with pLoF IFT140 variants (P = 2.9 × 10-9, odds ratio = 5.6 (95% CI, 3.3-9.2) in 100kG.

Study limitations: Retrospective study; IFT140-related cystic kidney disease may not be diagnosed in younger patients or patients with milder forms.

Conclusions: Individuals with monoallelic IFT140 pLoF variants are likely to develop kidney cysts atypical of classic ADPKD and generally have a favorable kidney prognosis.

Plain-language summary: Monoallelic pathogenic variants in IFT140 have been linked to a spectrum of kidney disease clinically similar to autosomal dominant polycystic kidney disease (ADPKD). This article describes a case series of 75 individuals with ADPKD-IFT140. Affected individuals typically presented with an atypical imaging pattern, had fewer but larger kidney cysts compared with classic ADPKD, and rarely developed liver cysts. Although the kidney prognosis appeared better than in classic ADPKD, 56.3% of individuals over 60 years of age had stage 3 or more severe CKD. Individuals with ADPKD-IFT140 variants are likely to develop kidney cyst patterns atypical of ADPKD. Their kidney prognosis appears favorable.

Keywords: ADPKD-like spectrum; IFT140; autosomal dominant polycystic kidney disease (ADPKD); case series; inherited kidney diseases; kidney function; loss of function variants; monoallelic IFT140-variants; polycystic kidney disease.

PubMed Disclaimer

Similar articles

Cited by

  • Clinical Relevance of IFT140 Loss-of-Function Variants in Development of Renal Cysts.
    Cristalli CP, Calabrese S, Caramanna L, Pietra A, Vitetta G, De Nicolo B, Bonora E, Severi G, Menabò S, Ferrari S, Ciurli F, Aiello V, Capelli I, Pasini A, Alberici I, Pillon R, La Scola C, Rossi C, Montanari F, Graziano C. Cristalli CP, et al. Genes (Basel). 2025 Apr 22;16(5):472. doi: 10.3390/genes16050472. Genes (Basel). 2025. PMID: 40428294 Free PMC article.
  • Characterizing the ADPKD-IFT140 Phenotypic Signature With Deep Learning and Advanced Imaging Biomarkers.
    Ghanem A, Munairdjy Debeh FG, Borghol AH, Zagorec N, Tapia AL, Smith B, Paul S, Basit A, AlKhatib B, Nader N, Bou Antoun MT, Gregory AV, Yang H, Schauer RS, Dahl NK, Hanna C, Torres VE, Kline TL, Harris PC, Cornec-Le Gall E, Chebib FT. Ghanem A, et al. Kidney Int Rep. 2025 May 7;10(8):2690-2707. doi: 10.1016/j.ekir.2025.04.062. eCollection 2025 Aug. Kidney Int Rep. 2025. PMID: 40814641 Free PMC article.

Substances